P-7788 Palbociclib, Hydrochloride Salt, >99%

Synonyms : [PD 332991]

Related Terms : [IBRANCE]

Prices_reduced
  • Size
  • US $
  • £
  • ¥
  • 50 mg
  • 39
  • 35
  • 30
  • 5,900
  • Add to Cart Qty:
  • In stock
  • 100 mg
  • 53
  • 48
  • 42
  • 8,000
  • Add to Cart Qty:
  • In stock
  • 200 mg
  • 78
  • 71
  • 61
  • 11,800
  • Add to Cart Qty:
  • In stock
  • 250 mg
  • 94
  • 86
  • 74
  • 14,300
  • Add to Cart Qty:
  • In stock
  • 500 mg
  • 133
  • 122
  • 105
  • 20,200
  • Add to Cart Qty:
  • In stock
  • 1 g
  • 226
  • 208
  • 179
  • 34,300
  • Add to Cart Qty:
  • In stock
  • 2 g
  • 349
  • 321
  • 277
  • 53,000
  • Add to Cart Qty:
  • In stock
  • 5 g
  • 670
  • 617
  • 531
  • 101,700
  • Add to Cart Qty:
  • In stock
  • 10 g
  • 1,150
  • 1,059
  • 913
  • 174,500
  • Add to Cart Qty:
  • In stock

Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.

To receive a Formal Quotation for catalog sizes of this product and/or any other products, please add them to your shopping cart and click on the “REQUEST A QUOTATION” box.
Click Here to Request a Quotation for Larger Quantities Free Shipping and Handling to the U.S. and 32 Other Countries
  • M.W. 483.99
  • C24H29N7O2HCl
  • [827022-32-2]

Select Lot Number to view Certificate of Analysis

View the SDS for this product

  • More than 160 labs worldwide have purchased Palbociclib or its salt forms from LC Labs (either directly from us or from our many distributors, many of whom resell under their own labels).
  • This research compound is the hydrochloride salt form of palbociclib; please see the free base form of palbociclib, Cat. No. [P-7744], Palbociclib, Free Base, for further technical information about this research compound. The other form of palbociclib available is Cat. No. [P-7766], Palbociclib, Isethionate Salt.
  • This palbociclib product is the hydrochloride salt, whose CAS number is given above. The CAS number of the free base form is 571190-30-2,  and the CAS number of the isethionate salt form is 827022-33-3.
  • Palbociclib (as the free base) is the active ingredient in the drug product sold under the trade name Ibrance®.  This drug is currently approved in a least one country for the treatment of adult patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer in combination with; an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women or in men; or fulvestrant in patients with disease progression following endocrine therapy.  NOTE:  THE PALBOCICLIB HYDROCHLORIDE SOLD BY LC LABORATORIES FOR RESEARCH IS NOT IBRANCE®, AND IS NOT FOR HUMAN USE.

  • Sold for laboratory or manufacturing purposes only; not for human, veterinary, food, or household use.
  • This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (vi) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries.
  • Not available in some countries; not available to some institutions; not available for some uses.
564